Updated May 9, 2018

Backing out of the Iran deal hurts Trump’s South Asia strategy

Iranian President Hassan Rouhani and Indian Prime Minister Narendra Modi in New Delhi on February 17, 2018. Photo: Iranian Presidency - Handout/Anadolu Agency/Getty Images

President Trump’s decision to withdraw from the nuclear deal with Iran doesn’t only deliver a blow to the global nonproliferation regime and stability in the Middle East. It also poses major risks for Washington’s South Asia strategy.

Why it matters: The administration’s objectives in South Asia include strengthening ties with India and weakening the Taliban in Afghanistan. Scuttling the Iran deal could undercut both goals.

Reimposing sanctions on Iran will complicate New Delhi’s ability to do business with Tehran, India’s third biggest oil supplier in 2017 and an increasingly important economic partner. If India becomes reluctant to invest in Iran, Tehran could seek deeper economic partnership with Pakistan and even consider joining the China-Pakistan Economic Corridor, a project opposed by New Delhi that deepens Beijing’s influence in South Asia. This could all generate tensions in a U.S.–India relationship that has grown rapidly in recent years.

Meanwhile, Tehran could retaliate against Trump’s move by ramping up military support to the Taliban in Afghanistan. U.S. officials believe Tehran is already providing small arms to the Taliban, and Afghan authorities claim Iran is already training Taliban units. Increased Iranian support to the Taliban would deepen America’s already-formidable challenges in Afghanistan.

The bottom line: The United States' withdrawal from the Iran deal could have far-reaching and deleterious consequences for its interests across the broader region.

Michael Kugelman is deputy director and senior associate for South Asia at the Wilson Center.

Go deeper

Serological coronavirus testing could be key to economic reopening

Illustration: Sarah Grillo/Axios

America's economy won't reopen anytime soon, despite frantic CEO whispers, but a glimmer of hope may be emerging in the form of serological testing.

Why it matters: Serologic tests aren't to determine whether or not you're infected with coronavirus. They are to determine if you have potential immunity that could allow you to safely return to work.

Government tech struggles to dole out coronavirus stimulus cash

Illustration: Eniola Odetunde/Axios

Tech challenges are hampering federal and state government efforts to get funds from the $2 trillion coronavirus relief law into the hands of newly unemployed workers and struggling small businesses who need it.

Why it matters: Many businesses and individuals need the money now for essentials, including meeting payroll and paying rent.

U.S. coronavirus updates: Death toll passes 9,600

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Andrew Witherspoon/Axios

Recorded deaths from the novel coronavirus surpassed 9,600 in the U.S. on Monday, per Johns Hopkins data. More than 1,000 people in the U.S. have died of coronavirus-related conditions each day since April 1.

Why it matters: U.S. Surgeon General Jerome Adams said on Sunday the coming week will be "the hardest and saddest week of most Americans' lives" — calling it our "our Pearl Harbor, our 9/11 moment."

Go deeperArrowUpdated 3 hours ago - Health